Announcements Trials
Browse Landscape

Phase

Phase 1 42Phase 1/2 27Phase 2 22Phase EARLY_PHASE1 9Phase NA 5Phase 2/3 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, B-Cell 1Hematologic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Immunotherapy, Adoptive × Clear all
NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting
210 enrolled
Lymphoid

Lymphoma, B-Cell

NCT06238336 2024-02-02

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Shanxi Bethune Hospital

Phase 2/3 Unknown
30 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02851784 2021-03-04

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Chinese PLA General Hospital

Phase 2/3 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡